rs57709964
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-C
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
- chr17-38840617-CAAAAAAAAAAAAAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001080465.3(SPMAP1):c.207+540_207+565delTTTTTTTTTTTTTTTTTTTTTTTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001080465.3 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000616  AC: 3AN: 48696Hom.:  0  Cov.: 0 show subpopulations 
GnomAD4 genome  0.0000616  AC: 3AN: 48696Hom.:  0  Cov.: 0 AF XY:  0.0000487  AC XY: 1AN XY: 20518 show subpopulations 
Age Distribution
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at